The BCG vaccine, an old treatment originally developed for tuberculosis, has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections -- possibly also against COVID-19. It is frequently given to children, but in this double-blind randomized clinical study, a collaboration between Radboud University Medical Center and the National and Kapodistrian University of Athens it was shown that elderly people also benefit from it. The results of the study are in Cell.

RESIST-TB released its August 2020 newsletter with the latest research publications on drug-resistant TB.

The Stop TB Partnership released its August 2020 newsletter, summarizing the initiatives and activities carried out during the month.

The International Union Against Tuberculosis and Lung Disease (The Union) released its August 2020 newsletter, summarizing the initiatives and activities carried out during the month.

The World Health Organization released target product profiles to drive the rapid development of novel TB preventive treatment. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

Dr Tereza Kasaeva, Director of the World Health Organization Global TB Program, released a message on the occasion of International Youth Day, 12 August.

The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.

A focus on the coronavirus has disrupted detection and treatment of other infectious diseases. Governments and funders can do four things to avert a catastrophe.

Member States of the World Health Organization adopt the Global Strategy for TB Research and Innovation at 73rd World Health Assembly.

A study of older mice with type 2 diabetes has yielded highly promising results for researchers investigating potential new vaccines for tuberculosis (TB).